Pavmed Inc Stock Today
| PAVM Stock | USD 0.66 0.05 8.20% |
PerformanceVery Weak
| Odds Of DistressHigh
|
PAVmed is selling at 0.66 as of the 17th of March 2025; that is 8.20 percent increase since the beginning of the trading day. The stock's lowest day price was 0.59. PAVmed has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 28th of April 2016 | Category Healthcare | Classification Health Care |
PAVmed Inc. operates as a medical device company in the United States. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Pavmed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 13.64 M outstanding shares of which 262.53 K shares are at this time shorted by private and institutional investors with about 1.43 trading days to cover. More on PAVmed Inc
Moving against PAVmed Stock
PAVmed Stock Highlights
| CFO President | Dennis CPA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPAVmed can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand PAVmed's financial leverage. It provides some insight into what part of PAVmed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PAVmed Inc (PAVM) is traded on NASDAQ Exchange in USA. It is located in 360 Madison Avenue, New York, NY, United States, 10017 and employs 107 people. PAVmed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9 M. PAVmed Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 13.64 M outstanding shares of which 262.53 K shares are at this time shorted by private and institutional investors with about 1.43 trading days to cover.
PAVmed Inc currently holds about 68.47 M in cash with (52.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PAVmed Probability Of Bankruptcy
Ownership AllocationPAVmed Inc has noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check PAVmed Ownership Details
PAVmed Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Cwm, Llc Duplicate | 2024-12-31 | 4.7 K | |
| Tower Research Capital Llc | 2024-12-31 | 4.5 K | |
| Wells Fargo & Co | 2024-12-31 | 2.4 K | |
| Atlantic Trust Group, Llc | 836 | ||
| Bank Of America Corp | 2024-12-31 | 349 | |
| Hanson Mcclain Inc | 2024-12-31 | 295 | |
| Sbi Securities Co Ltd | 2024-12-31 | 108 | |
| Parallel Advisors, Llc | 2024-12-31 | 78.0 | |
| Advisor Group Holdings, Inc. | 2024-12-31 | 74.0 | |
| First Manhattan Co. Llc | 2024-12-31 | 700 K | |
| Vanguard Group Inc | 2024-12-31 | 81.5 K |
PAVmed Historical Income Statement
PAVmed Stock Against Markets
PAVmed Corporate Management
| Michael Gordon | General VP | Profile | |
| Deepika Lakhani | Chief VP | Profile | |
| Lishan MD | Chairman CEO | Profile | |
| Michael Parks | Vice Relations | Profile | |
| Adrian Miller | VP Relations | Profile | |
| Brian MD | Chief Affairs | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share | Quarterly Revenue Growth 0.259 | Return On Assets | Return On Equity |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.